Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/20/10 → 12/31/14 |
Funding
- Wyeth Pharmaceuticals Inc: $130,568.00
A Phase 3, Open-Label Single Arm Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 3 Doses of 13-Valent Pneumococcal Conjugate Vaccine in Human Immunodeficiency Virus Subjects 18 Years of Age or Older
- Greenberg, Richard (PI)